PD-1 (also called PDCD1, CD279) is expressed on immune cells, especially tumor specific T cells, while PD-1 ligand PD-L1 (also called B7-H1, CD274) is expressed on tumor cells as an “adaptive immune mechanism” to escape anti-tumor response (Han, Liu & Li, 2020). The gene discussed is CD274; the disease is neoplasm.